|
|
Volumn 610, Issue , 2008, Pages 155-176
|
|
Monoclonal antibodies in the treatment of malignant lymphomas
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALEMTUZUMAB;
ANTINEOPLASTIC AGENT;
APOLIZUMAB;
CARBOPLATIN;
CHLORAMBUCIL;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DENILEUKIN DIFTITOX;
DEXAMETHASONE;
DOXORUBICIN;
EPRATUZUMAB;
ETOPOSIDE;
FLUDARABINE;
GALIXIMAB;
IBRITUMOMAB TIUXETAN;
IFOSFAMIDE;
INTERFERON;
MITOXANTRONE;
OCRELIZUMAB;
PREDNISOLONE;
PREDNISONE;
RITUXIMAB;
TOSITUMOMAB I 131;
VINCRISTINE;
MONOCLONAL ANTIBODY;
ACUTE LUNG INJURY;
ANGIONEUROTIC EDEMA;
AUTOLOGOUS STEM CELL TRANSPLANTATION;
B CELL LYMPHOMA;
BLOOD TOXICITY;
BRONCHOSPASM;
CANCER RELAPSE;
CHILL;
CHRONIC LYMPHATIC LEUKEMIA;
CLINICAL TRIAL;
COUGHING;
DIZZINESS;
DRUG DOSE ESCALATION;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG POTENTIATION;
DRUG SAFETY;
DRUG TOLERABILITY;
FATIGUE;
FEVER;
FOLLICULAR LYMPHOMA;
HUMAN;
HYPOTENSION;
INFECTION;
LUNG DISEASE;
LYMPHOMA;
MANTLE CELL LYMPHOMA;
MARGINAL ZONE LYMPHOMA;
NAUSEA;
NEUTROPENIA;
PRIORITY JOURNAL;
PRURITUS;
REVIEW;
THROAT DISEASE;
TREATMENT RESPONSE;
ANIMAL;
CHEMISTRY;
IMMUNOTHERAPY;
METASTASIS;
METHODOLOGY;
ONCOLOGY;
RANDOMIZED CONTROLLED TRIAL;
ANIMALS;
ANTIBODIES, MONOCLONAL;
CLINICAL TRIALS AS TOPIC;
HUMANS;
IMMUNOTHERAPY;
LYMPHOMA;
LYMPHOMA, FOLLICULAR;
MEDICAL ONCOLOGY;
NEOPLASM METASTASIS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
|
|
EID: 47949123506
PISSN: 00652598
EISSN: None
Source Type: Book Series
DOI: 10.1007/978-0-387-73898-7_12 Document Type: Review |
|
Times cited : (3)
|
|
References (0)
|
